Back

A novel cortical biomarker signature accurately and reliably predicts individual pain sensitivity: The PREDICT longitudinal analytical validation study

2024-06-17 pain medicine Title + abstract only
View on medRxiv
Show abstract

ImportanceBiomarkers would greatly assist decision making in the diagnosis, prevention and treatment of chronic pain. ObjectiveThe present study aimed to undertake analytical validation of a sensorimotor cortical biomarker signature for pain consisting of two measures: sensorimotor peak alpha frequency (PAF) and corticomotor excitability (CME). DesignIn this cohort study (recruitment period: November 2020-October 2022), participants experienced a model of prolonged temporomandibular pain with ...

Predicted journal destinations